Opisthorchiasis felinea is a common infection of cats, foxes, dogs, pigs and other fish-eating mammals (reservoir final hosts) in a wide geographical area extending from eastern Europe to central Asia and Siberia. The transmission cycle is similar to that of clonorchiasis and opisthorchiasis viverrini: the adult worms live in the bile ducts and lay eggs that are dispersed into the environment through defecation.
When they reach freshwater, eggs develop into miracidia that are ingested by various species of aquatic snails, where they develop into larvae and reproduce asexually, producing numerous cercariae. Cercariae leave the snail and pass into water, where they swim to penetrate beneath the scales of various species of carp-like freshwater fish where, as metacercariae, they encyst the subcutaneous tissue. When carnivores eat raw fish, the metacercarial cysts hatch in the intestine and the young worms migrate to the bile ducts, thus completing the cycle.
Humans may substitute reservoir hosts in the transmission cycle when they eat raw, undercooked or poorly processed fish and ingest the metacercariae. In areas where O. felineus is endemic, fish is frequently eaten frozen, salted and smoked.
In humans, acute opisthorchiasis felinea may be asymptomatic or scarcely symptomatic in light infections, but if the number of worms is significant (up to several thousands), fever and right upper-quadrant pain are not infrequent and may be associated with intermittent colic pain caused by obstruction of the gallbladder by the worms themselves. Typically, opisthorchiasis felinea is associated with a more pronounced and severe acute phase than opisthorchiasis viverrini or clonorchiasis.
Not much information is available on chronic opisthorchiasis felinea: the presence of the worms in the smaller bile ducts is likely to cause chronic inflammation of their walls, resulting in fibrosis of the ducts and destruction of the adjacent liver parenchyma. Recurrent pyogenic cholangitis may be present. There is insufficient evidence to establish a causal link between opisthorchiasis felinea and cholangiocarcinoma or other forms of liver cancer. The International Agency for Research on Cancer (IARC) classifies O. felineus as a Group 3 agent (not classifiable as to its carcinogenicity to humans).
Diagnosis, treatment and control
Diagnosis of opisthorchiasis felinea is suspected on the basis of the clinical picture, on the anamnestic recall of consuming raw fish, on the detection of eosinophilia, and on typical findings of ultrasound, computed tomography or magnetic resonance imaging scans. Confirmation of diagnosis relies on different types of diagnostic techniques:
- parasitological techniques to detect Opisthorchis eggs in stool samples; their cost and sensitivity may vary according to the type of technique used; they can only be employed in the chronic phase; some techniques, such as the Kato-Katz thick smear, quantify
- immunological techniques to detect worm-specific antibodies in serum samples or worm-specific antigens in serum or stool samples; these techniques are usually more sensitive than the commonly used parasitological techniques; detection of antibodies does not distinguish between current, recent and past infections; their ability to quantify intensity of infection is disputed; stool tests are easier to perform and reportedly better accepted by individuals in endemic areas; these techniques are still at an experimental stage;
- molecular techniques such as the polymerase chain reaction are also at an experimental stage.
Praziquantel is the only medicine recommended by WHO for treatment of opisthorchiasis felinea. It should be administered at the dose of 25 mg/kg 3 times daily for 2–3 consecutive days or of 40 mg/kg, single administration.
There is insufficient information on the epidemiological pattern of opisthorchiasis felinea to generate adequate recommendations for public health control. As an interim measure, WHO recommends following the same guidelines as those for opisthorchiasis viverrini and clonorchiasis: community diagnosis carried out at the district level, and preventive chemotherapy implemented using single administrations of praziquantel at 40 mg/kg, as indicated by the following table:
Complementary interventions such as information, education and communication on safe food practices, improved sanitation and veterinary public health measures should also be implemented in order to decrease transmission rates.